Cargando…
Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
SIMPLE SUMMARY: Cancer immunotherapy is gaining attention as a potential fourth treatment following surgery, chemotherapy, and radiation therapy. Cancer stem cells have recently been recognized and validated as a key target for cancer treatment. Cripto-1, which is a GPI-anchored membrane-bound prote...
Autores principales: | Ishii, Hiroko, Afify, Said M., Hassan, Ghmkin, Salomon, David S., Seno, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160785/ https://www.ncbi.nlm.nih.gov/pubmed/34065315 http://dx.doi.org/10.3390/cancers13102491 |
Ejemplares similares
-
Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018) -
Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs
por: Osman, Amira, et al.
Publicado: (2020) -
Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
por: Nawara, Hend M., et al.
Publicado: (2021) -
Metastasis Model of Cancer Stem Cell-Derived Tumors
por: Mansour, Hager, et al.
Publicado: (2020) -
A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
por: Ishii, Hiroko, et al.
Publicado: (2021)